QNRX CIK: 1671502

Quoin Pharmaceuticals Ltd.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.06
FY22:
−9.26
FY23:
−9.38
FY24:
−9.53
FY25:
−16.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.3
FY22:
−8.98
FY23:
−8.58
FY24:
−9.44
FY25:
−16.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.5
FY22:
−9.38
FY23:
−8.69
FY24:
−8.96
FY25:
−15.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.5
FY22:
−9.38
FY23:
−8.69
FY24:
−8.96
FY25:
−15.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data